Numeta G19%e (Valine, Ornithine Hydrochloride, Alanine, Arginine, Cysteine, Histidine, Isoleucine, Leucine, Methio)

Numeta G19%e, an amino acid supplement, supports metabolic and nutritional pathways in catabolic conditions.

• Protein‑energy malnutrition: helps restore nitrogen balance and lean body mass.
• Post‑operative recovery: provides essential amino acids for tissue repair and wound healing.
• Chronic kidney disease (dialysis patients): supplies a balanced amino acid profile to counteract losses during treatment.
• Severe burns: assists in rebuilding damaged protein structures and supports immune function.

• The amino acids in Numeta G19%e act as fundamental building blocks for protein synthesis, stimulate mTOR signaling pathways, and improve nitrogen balance. By supplying essential and conditionally essential residues, the formulation enhances cellular repair, supports gluconeogenesis, and contributes to the replenishment of depleted plasma amino acid pools during catabolic stress.

Common Side Effects

• Nausea: mild stomach upset may occur after ingestion.
• Diarrhea: loose stools are reported in some users.
• Headache: transient headache can be experienced.
• Metallic taste: a temporary metallic sensation in the mouth.
• Mild hyperammonemia: slight elevation of blood ammonia levels.

Serious or Rare Side Effects

• Allergic reaction: rash, itching, or swelling of the face and throat.
• Anaphylaxis: severe, life‑threatening hypersensitivity requiring immediate medical attention.
• Severe hyperammonemia: significant rise in ammonia that may cause neurological symptoms.
• Metabolic acidosis: rare disturbance of blood pH balance.
• Renal overload: excessive nitrogen load leading to impaired kidney function.

Before initiating therapy, consider the following precautions:

• Assess renal function: adjust use in patients with impaired kidney function.
• Monitor liver function: watch for elevated liver enzymes during prolonged use.
• Avoid in known hypersensitivity: discontinue if allergic signs appear.
• Use caution in pregnancy: limited data, weigh potential benefits against risks.
• Avoid excessive concurrent protein intake: supervise combined dietary protein sources.
• Store at ambient temperature: keep in the original container, protect from moisture and light.

Potential drug interactions should be reviewed prior to prescribing.

Major Interactions (Avoid)

• High‑dose nitrogenous waste‑producing drugs (e.g., valproic acid): may exacerbate hyperammonemia.
• Monoamine oxidase inhibitors combined with arginine‑rich formulations: could increase hypertensive risk.

Moderate Interactions (Monitor Closely)

• Diuretics: may alter electrolyte balance when combined with amino acid supplementation.
• Concurrent protein supplements: can increase nitrogen load and stress renal clearance.
• Broad‑spectrum antibiotics: may affect gut flora and modify amino acid absorption.